Vaccines

An ‘inverse vaccine’ has been developed that reverses the damage caused when the immune system mistakenly attacks the body’s healthy organs and tissues. It could pave the way to a treatment for autoimmune diseases like MS, type 1 diabetes and arthritis.

Researchers are close to human clinical trials to test the safety and efficacy of vaccines to prevent heroin and fentanyl overdoses. If approved, they could revolutionize the treatment of opioid addiction and reduce deaths from overdose.

A study last year found that the influenza vaccine reduced the risk of Alzheimer's disease. Now, the same research team has found that people aged 65 and over who’ve received routine vaccinations are significantly less likely to develop the condition.

Researchers have developed a groundbreaking vaccine that generates immunity against the Epstein-Barr virus, a virus that almost all of us carry and which has been found to be a primary cause of diseases like multiple sclerosis and some cancers.

Caltech scientists have developed a new hybrid vaccine that combines mRNA and protein nanoparticles. In mouse tests, the prototype produced five times more antibodies than existing COVID-19 vaccines, and could be used against a range of diseases.

Researchers have designed a new nanoparticle that was shown to more effectively deliver a cancer-fighting mRNA vaccine to mice. The study’s results may lead to the development of better vaccines to treat cancer and infectious diseases like COVID-19.

Biotech giant Vaxxas has cut the ribbon on a warehouse manufacturing plant for its needle-free patches. After successful trials, the first needle-free, easy to store and easy to administer vaccines are set to be rolled out in as little as three years.

It may seem like snail's pace compared to our COVID-19 vaccines, but the wheels are certainly turning in the development of a universal mRNA influenza vaccine. The latest has just entered trial, with many others at the same stage or even further along.

Three times more men than women develop mouth and throat cancers, most likely caused by HPV, the world's most common STI. There's a vaccine that can prevent 90% of these HPV-related cancers, however it's mainly women getting the shots.

Researchers have developed a mobile printer that creates temperature-stable, dissolvable vaccine patches on demand. The novel device not only does away with vaccine injections, but it would also enable vaccines to be delivered to remote areas.

If you’ve ever eaten something questionable and gotten sick for a few days, chances are you’ve had a norovirus. It's surprisingly tricky to treat or prevent, but now scientists have made progress on a vaccine by tweaking a different foodborne virus.

The world got COVID vaccines at a record pace, but RNA therapies for diseases has felt like it is still in a galaxy far, far away. A team of scientists now believe they're on the edge of the next frontier, harnessing the activity of RNA-editing enzymes.